Thyme Care raises $125.0M Series E (United States, Sep 2026)
Reach the investors backing rounds like this
Backed by Morgan Health, Humana +4 more · verified emails and LinkedIn on Datapile
Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion - CNBC
Thyme Care is a cancer care startup that focuses on improving patient treatment through a virtual navigation platform. The company aims to address gaps in cancer care, including drug affordability and clinical trial access, and has expanded its services to over 10.5 million people across the U.S.
Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion CNBC
| Sep 03, 2026 | Plenti | $3.0M | — | United States |
| Sep 02, 2026 | TabaPay | $155.0M | — | United States |
| Sep 02, 2026 | Lyte | $165.0M | Series C | United States |
| Sep 02, 2026 | HiddenLayer | $100.0M | Series B | United States |
20,206 investors back startups in United States
You just read who funded Thyme Care. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.